FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

409406007: Bevacizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2464857019 Bevacizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2471192013 Bevacizumab en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bevacizumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Bevacizumab Is a Substance with angiogenesis inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Bevacizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Bevacizumab Has disposition Angiogenesis inhibitor true Inferred relationship Existential restriction modifier
Bevacizumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Bevacizumab Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier
Bevacizumab Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing bevacizumab Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier 1
Bevacizumab 25mg/mL injection solution 4mL vial Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 25mg/mL injection solution 16mL vial Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Product containing bevacizumab in parenteral dose form (medicinal product form) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial Has basis of strength substance False Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial Has precise active ingredient False Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial Has basis of strength substance False Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial Has precise active ingredient False Bevacizumab Inferred relationship Existential restriction modifier 1
Bevacizumab Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing only bevacizumab in parenteral dose form (medicinal product form) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Bevacizumab Inferred relationship Existential restriction modifier 1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Bevacizumab Inferred relationship Existential restriction modifier 1
Bevacizumab 5mg/0.2ml solution for injection pre-filled syringes Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 5mg/0.2ml solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 5mg/0.2ml solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 5mg/0.2ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Vegzelma 400mg/16ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Vegzelma 400mg/16ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Vegzelma 100mg/4ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Vegzelma 100mg/4ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Alymsys 100mg/4ml concentrate for solution for infusion vials (Zentiva Pharma UK Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Alymsys 400mg/16ml concentrate for solution for infusion vials (Zentiva Pharma UK Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Alymsys 400mg/16ml concentrate for solution for infusion vials (Zentiva Pharma UK Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Alymsys 100mg/4ml concentrate for solution for infusion vials (Zentiva Pharma UK Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Oyavas 100mg/4ml concentrate for solution for infusion vials (Thornton & Ross Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Oyavas 400mg/16ml concentrate for solution for infusion vials (Thornton & Ross Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Oyavas 400mg/16ml concentrate for solution for infusion vials (Thornton & Ross Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Oyavas 100mg/4ml concentrate for solution for infusion vials (Thornton & Ross Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 400mg/16ml solution for injection vials (Roche Products Ltd) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 100mg/4ml solution for injection vials (Roche Products Ltd) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Zirabev 400mg/16ml solution for infusion vials (Pfizer Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Zirabev 400mg/16ml solution for infusion vials (Pfizer Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Zirabev 100mg/4ml solution for infusion vials (Pfizer Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Zirabev 100mg/4ml solution for infusion vials (Pfizer Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for injection vials 1 vial Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for injection vials 1 vial Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Aybintio 400mg/16ml solution for infusion vials (Organon Pharma (UK) Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Aybintio 400mg/16ml solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 400mg/16ml solution for injection vials (Roche Products Ltd) 1 vial Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Avastin 100mg/4ml solution for injection vials (Roche Products Ltd) 1 vial Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Avastin 400mg/16ml solution for injection vials (Roche Products Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 25mg/mL injection solution 16mL vial Has specific active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Avastin 400mg/16ml solution for injection vials (Roche Products Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for injection vials 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 100mg/4ml solution for injection vials (Roche Products Ltd) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 25mg/mL injection solution 4mL vial Has specific active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Avastin 100mg/4ml solution for injection vials (Roche Products Ltd) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for injection vials 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 1.25mg/0.05ml solution for injection vials (Special Order) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 1.25mg/0.05ml solution for injection vials (Special Order) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials 1 ml Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Avastin 1.25mg/0.05ml solution for injection vials (Special Order) 1 ml Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials (Special Order) 1 vial Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes (Special Order) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes 50 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes 10 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes (Special Order) 10 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes (Special Order) 50 pre-filled disposable injection Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops (Special Order) Has active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops (Special Order) Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops 4 ml Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops (Special Order) 4 ml Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Has specific active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Has specific active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Has active ingredient False Bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Has specific active ingredient True Bevacizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start